Administration of CD4+CD25highCD127−FoxP3+ Regulatory T Cells for Relapsing-Remitting Multiple Sclerosis: A Phase 1 Study
Kamil Chwojnicki, Dorota Iwaszkiewicz‐Grześ, Anna Jankowska, Maciej Zieliński, Paweł Łowiec, Mateusz Gliwiński, Małgorzata Grzywińska, Kamil Kowalczyk, Aleksandra Konarzewska, Paulina Glasner, Justyna Sakowska, Julia Kulczycka, Anna Jaźwińska-Curyłło, Marlena Kubach, Bartosz Karaszewski, Walenty M. Nyka, Edyta Szurowska, Piotr Trzonkowski
Topics & Concepts
Multiple sclerosisMedicineExpanded Disability Status ScaleFOXP3Adverse effectClinically isolated syndromeImmune systemInternal medicineEx vivoImmunologyClinical trialRelapsing remittingRegulatory T cellIn vivoIL-2 receptorT cellBiologyBiotechnologyMultiple Sclerosis Research StudiesT-cell and B-cell Immunologyvaccines and immunoinformatics approaches